ADIAL PHARMACEUTICALS, INC. - 8-K Filing
Adial Pharmaceuticals amended its securities purchase and note exchange agreements on September 16, 2026, removing a penalty provision that caused Milestone Warrants to be classified as liabilities. (Items: 1.01 Entry into a Material Definitive Agreement, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $ADIL